Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kassiou

Showing results (41-50 of 231) with videos related to

Pageof 24
Sort By:
Chemical Reviews|June 7, 2023
Late-stage Functionalization for Improving Drug-like Molecular PropertiesNathan J Castellino, Andrew P Montgomery, Jonathan J Danon, et al.
The Journal of Organic Chemistry|May 10, 2016
The Formation of Seven-Membered Heterocycles under Mild Pictet-Spengler Conditions: A Route to Pyrazolo[3,4]benzodiazepinesTimothy A Katte, Tristan A Reekie, William T Jorgensen, et al.
Trends in Pharmacological Sciences|December 23, 2019
Insight into the Structural Features of TSPO: Implications for Drug DevelopmentJean-Jacques Lacapere, Luminita Duma, Stephanie Finet, et al.
CNS Drugs|August 6, 2015
The therapeutic potential of α7 nicotinic acetylcholine receptor (α7 nAChR) agonists for the treatment of the cognitive deficits associated with schizophreniaCorinne Beinat, Samuel D Banister, Marco Herrera, et al.
Behavioural Brain Research|April 2, 2008
Behavioural effects of trishomocubanes in rats with unilateral 6-hydroxydopamine lesionsAddy van Dijk, Christopher Johnston, Haydn Allbutt, et al.
The International Journal of Biochemistry & Cell Biology|March 23, 2013
The translocator protein (TSPO): a novel target for cancer chemotherapyChristopher J D Austin, Jan Kahlert, Michael Kassiou, et al.
Expert Opinion on Drug Discovery|April 28, 2023
An update on late-stage functionalization in today's drug discoveryAndrew P Montgomery, Jack M Joyce, Jonathan J Danon, et al.
British Journal of Pharmacology|May 26, 2012
Inhibition of human recombinant T-type calcium channels by N-arachidonoyl 5-HTAndrew J Gilmore, Marika Heblinski, Aaron Reynolds, et al.
ACS Chemical Neuroscience|May 5, 2022
Purinergic P2X<sub>7</sub> Receptor: A Therapeutic Target in Amyotrophic Lateral SclerosisAndré D J Mckenzie, Taylor R Garrett, Eryn L Werry, et al.
Current Topics in Medicinal Chemistry|June 30, 2010
PET radioligands for the vesicular acetylcholine transporter (VAChT)Nicolas Giboureau, Ian Mat Som, Aurélie Boucher-Arnold, et al.
Pageof 24

Showing results (41-50 of 231) with videos related to

Sort By:
Pageof 24
Chemical Reviews|June 7, 2023
Late-stage Functionalization for Improving Drug-like Molecular PropertiesNathan J Castellino, Andrew P Montgomery, Jonathan J Danon, et al.
The Journal of Organic Chemistry|May 10, 2016
The Formation of Seven-Membered Heterocycles under Mild Pictet-Spengler Conditions: A Route to Pyrazolo[3,4]benzodiazepinesTimothy A Katte, Tristan A Reekie, William T Jorgensen, et al.
Trends in Pharmacological Sciences|December 23, 2019
Insight into the Structural Features of TSPO: Implications for Drug DevelopmentJean-Jacques Lacapere, Luminita Duma, Stephanie Finet, et al.
CNS Drugs|August 6, 2015
The therapeutic potential of α7 nicotinic acetylcholine receptor (α7 nAChR) agonists for the treatment of the cognitive deficits associated with schizophreniaCorinne Beinat, Samuel D Banister, Marco Herrera, et al.
Behavioural Brain Research|April 2, 2008
Behavioural effects of trishomocubanes in rats with unilateral 6-hydroxydopamine lesionsAddy van Dijk, Christopher Johnston, Haydn Allbutt, et al.
The International Journal of Biochemistry & Cell Biology|March 23, 2013
The translocator protein (TSPO): a novel target for cancer chemotherapyChristopher J D Austin, Jan Kahlert, Michael Kassiou, et al.
Expert Opinion on Drug Discovery|April 28, 2023
An update on late-stage functionalization in today's drug discoveryAndrew P Montgomery, Jack M Joyce, Jonathan J Danon, et al.
British Journal of Pharmacology|May 26, 2012
Inhibition of human recombinant T-type calcium channels by N-arachidonoyl 5-HTAndrew J Gilmore, Marika Heblinski, Aaron Reynolds, et al.
ACS Chemical Neuroscience|May 5, 2022
Purinergic P2X<sub>7</sub> Receptor: A Therapeutic Target in Amyotrophic Lateral SclerosisAndré D J Mckenzie, Taylor R Garrett, Eryn L Werry, et al.
Current Topics in Medicinal Chemistry|June 30, 2010
PET radioligands for the vesicular acetylcholine transporter (VAChT)Nicolas Giboureau, Ian Mat Som, Aurélie Boucher-Arnold, et al.
Pageof 24